Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs LCID✓SelectedUSD · LCIDMRNA vs LCID performance historyLatest closeAs of-3.63%11/16
Stock and ETF performance explorer

MRNA vs LCID

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+181.2%
LCID return
-93.4%
Excess return
+274.7%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioLCIDExcessAlpha
1D-3.6%-5.2%+1.6%-2.3%
7D-20.0%-22.2%+2.2%-14.9%
30D-1.3%-10.5%+9.3%+0.7%
3M+240.0%-55.0%+295.0%+309.9%
6M+339.0%-53.6%+392.6%+408.5%
YTD+630.0%-73.5%+703.5%+842.4%
1Y+769.1%-80.3%+849.4%+1,086.5%
3Y+181.2%-93.5%+274.7%+361.2%
All+181.2%-93.4%+274.7%+361.2%

Cumulative growth

Daily Returns

Daily percentage return beside LCID.

Daily Out/Under-Performance

Portfolio return minus LCID return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling